Atlas Trials

Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection

Clinical trial NCT03022981 · COMPLETED

Trial details

NCT number
NCT03022981
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C Virus Infection
Start date
2017-01-26
Primary completion
2019-11-19
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.